Max Neeman International, Max India’s full service Clinical Research Organization is headquartered in Delhi, with its US offices in Research Triangle Park, NC.

Max Neeman International has the backing of this $2.0 billion life sciences consortium, owning twelve hospitals and managing other healthcare businesses in life insurance and healthcare.

Most of the major Pharma's have a presence in India – with most all, working with Max Neeman. In addition 
Max Neeman Group has supported 85 Biotech and Device firms.

Having completed [forty five] successful sponsor and site audits, we are also the first India based CRO holding recently acquired ISO-9000 certification. In addition, ISO 27001 and ISO 14155.

Max Neeman International is able to assist the pharmaceutical, biotech and device industry in all aspects of conducting clinical trials in India and worldwide.

SERVICES:
•Phase I-IV study management
•Feasibility study and protocol design
•Clinical development strategies
•Project management
•Site monitoring
•Medical monitoring
•Site management
•Data management / EDC & Legacy data conversion
•Statistical analysis and reporting
•Regulatory services 
•Import/export licenses
•Pharmacy and drug distribution services
•Safety monitoring 
•Medical writing

COMPANY HIGHLIGHTS:

• Offices strategically placed throughout India, increasing recruitment, sustaining hospital relationships and attracting top talent. relationships with 900 ICH GCP trained investigators across 175 Sites.

Biotechnology

Clinical Trials

Health Care

Pharmaceutical

Max Neeman International

Stefan Hughes

Ankit Jain

Sandeep Ramanuj

Manupriya Verma

Dr.manoj Sharma

Dr. Kamakshi Sharma

Babu Mahalingam

Navneet Raut

Arun Srivastava

Devbrat Shukla

Dr. Shariq Anwar

Ravindra Bhadauria

Ghazanfar Husain

Max Neeman International

Org chart

Similar companies